MANE
Veradermics, Inc
A clinical-stage biopharmaceutical company developing VDPHL01, an oral, non-hormonal extended-release form of minoxidil designed to grow hair while limiting heart-related side effects, for men and women with pattern hair loss. It was founded in 2019 by dermatologists who met at MIT's Hacking Dermatology competition, and its name blends the Latin for "true" with the Greek for "skin."
CUSIP: 9229671042 holders
Total Value
$289.09M
Total Shares
2.35M
Net Share Change
+660.9K
Activity
1 buying1 selling
Investor
Value
Shares
Weight
Change
